Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: Evidence for evolutionary differences

Journal of Pharmacology and Experimental Therapeutics

Volumn 296, Issue 1, 2001, Pages 113-120

  Dautzenberg, Frank M ^a,b   Py Lang, Gabrielle ^a   Higelin, Jacqueline ^a   Fischer, Christophe ^a   Wright, Matthew B ^a   Huber, Gerda ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b Preclinical Research   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ASTRESSIN; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; IODINE 125; RADIOLIGAND; SAUVAGINE; UROCORTIN;

AMPHIBIA; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; COMPARATIVE STUDY; EVOLUTION; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; XENOPUS;

ANIMALS; BINDING, COMPETITIVE; CELL LINE; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP; EVOLUTION; HUMANS; IODINE RADIOISOTOPES; LIGANDS; PEPTIDES; RADIOLIGAND ASSAY; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; XENOPUS;

EID: 0035198180     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. The role of corticotropin-releasing factor in depression and anxiety disorders
2. 2 α and β splice variants: Pharmacological characterization using radioligand binding and a luciferase gene expression assay
3. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF binding protein: Implications for the treatment of CNS disorders
4. Urocortin expression in rat brain: Evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors
5. Identification of two corticotropin-releasing factor receptors with high ligand selectivity from Xenopus laevis: Unusual pharmacology of the type 1 receptor
6. 2α receptors and the role of position 185 for recepter-ligand selectivity
7. The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptors reside in different extracellular domains: Generation of chimeric receptors with a novel ligand-selective profile
8. Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: Implications for the ligand-binding site
9. Cloning and characterization of human urocortin
10. Regulation of the stress response by corticotropin-releasing factor receptors
11. Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: Rapid and reversible homologous desensitization but prolonged recovery
12. High intracerebral levels of CRH result in CRH receptor downregulation in the amygdala and neuroimmune desensitization
13. 125I-Antisauvagine-30: A novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors
14. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
15. Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry
16. G-protein coupled receptors - The splicing on the cake
17. Localization of ligand-binding domains of human corticotropin-releasing factor receptor: A chimeric receptor approach
18. Evolution and physiology of the corticotropinreleasing factor (CRF) family of neuropeptides in vertebrates
19. Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri
20. Corticotropin-releasing factor receptor type 1 from Tupaia belangeri: Cloning, functional expression and tissue distribution
21. The first extracellular domain of corticotropin-releasing factor-R1 contains major binding determinants for urocortin and astressin
22. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors
23. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: Differential roles of CRF receptors 1 and 2
24. High-affinity binding of urocortin and astressin but not CRF to G protein-uncoupled CRFR1
25. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): Development of CRFR2β-selective antisauvagine-30
26. Synthesis and characterization of a photoactivatable analog of corticotropin-releasing factor for specific receptor labeling
27. Radiolabelling of the human 5-HT2: A receptor with an agonist, a partial agonist and an antagonist: Effects on apparent agonist affinities
28. Molecular properties of the CRF receptor
29. Corticotropin-releasing factor (CRF) family of ligands and their receptors
30. Urocortin, a mamalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor
31. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high affinity ligand binding